Info
Addiction Research and Evaluation : Addressing Key Challenges for Policy and Practice / / by Catherine Comiskey
| Addiction Research and Evaluation : Addressing Key Challenges for Policy and Practice / / by Catherine Comiskey |
| Autore | Comiskey Catherine |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (228 pages) |
| Disciplina | 613.83 |
| Collana | Advances in Mental Health and Addiction |
| Soggetto topico |
Psychology
Mental health Psychic trauma Pharmacovigilance Medical policy Behavioral Sciences and Psychology Mental Health Trauma Psychology Drug Safety and Pharmacovigilance Health Policy |
| ISBN | 3-031-65917-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1 Introduction: What challenges are policy and practice facing. - Chapter 2 Prevalence: What is the nature and scale of the problem? -- Chapter 3 Addressing needs: What do our clients, staff and community need? -- Chapter 4 Prevention and intervention: What are the components of successful interventions? -- Chapter 5 Outreach, treatment and recovery: Understanding and evaluating an outreach, treatment or recovery intervention -- Chapter 6 Disaster preparedness, rapid assessment, response, recovery and foresight: Responding to unplanned events and emerging threats -- Chapter 7 Mortality, overdose and drug related deaths: How do we address overdose deaths and underlying risk and protective factors? -- Chapter 8 Strengths based approaches addressing stigma and trauma: How do we address stigma and develop trauma informed approaches? -- Chapter 9 Policy and practice development: How do we develop a shared strategy? -- Chapter 10 Implementation, monitoring and evaluation: What enablers do we need and when do we need them to ensure success? -- Chapter 11 Disruptive innovation, sustainability and sharing best practice: How to be innovative, sustainable and share learning. |
| Record Nr. | UNINA-9910887891703321 |
Comiskey Catherine
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad
| Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 |
| Descrizione fisica | 1 online resource (XII, 314 p. 95 illus., 91 illus. in color.) |
| Disciplina | 353.998 |
| Soggetto topico |
Pharmacy
Pharmacology Drug Safety and Pharmacovigilance Pharmacology/Toxicology |
| ISBN | 981-13-1489-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions. |
| Record Nr. | UNINA-9910350239403321 |
| Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Genomics : Methods and Applications / / edited by Vijai Singh
| Advances in Genomics : Methods and Applications / / edited by Vijai Singh |
| Autore | Singh Vijai |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (424 pages) |
| Disciplina | 576.5 |
| Soggetto topico |
Genetics
Genomics Genetic transcription Pharmacovigilance Synthetic Biology Biology - Technique Genetics and Genomics Gene Transcription Drug Safety and Pharmacovigilance Biological Techniques |
| ISBN |
9789819731695
9789819731688 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction to genomics and their applications -- Chapter 2. Methods for generating genomics data -- Chapter 3. Computational tools for genomics data analysis -- Chapter 4. Gene and genome annotation -- Chapter 5. Transcriptomics and their significance -- Chapter 6. DNA barcoding and its applications -- Chapter 7. Next-generation genome sequencing and its use -- Chapter 8. Genome-wise analysis for drug targeting -- Chapter 9. Functional genomics -- Chapter 10. Metagenomics -- Chapter 11. Synthetic genomics.-Chapter 12. Microarray in genomics -- Chapter 13. Nutrigenomics -- Chapter 14. Role of synthetic biology in genomics -- Chapter 15. Role of genome editing in genomics -- Chapter 16. Mitochondrial genomics and their clinical use -- Chapter 17. Chloroplast genomics and their uses in crop improvement -- Chapter 18. Microfluidics in genomics -- Chapter 19. Cell-free systems for genomics -- Chapter 20. Artificial intelligence in genomics. |
| Record Nr. | UNINA-9910878988203321 |
|
Singh Vijai
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Pharmaceutical Product Development / / edited by Keerti Jain, Awesh K. Yadav
| Advances in Pharmaceutical Product Development / / edited by Keerti Jain, Awesh K. Yadav |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (XV, 443 p. 57 illus., 54 illus. in color.) |
| Disciplina | 615 |
| Collana | Medicine Series |
| Soggetto topico |
Pharmacology
Drug delivery systems Pharmacovigilance Drug Delivery Drug Safety and Pharmacovigilance |
| ISBN | 981-9792-30-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Advances in Development of Pharmaceutical Products -- Design of Materials and Product Specifications for Pharmaceutical Dosage Forms -- Optimization Techniques for Development of Pharmaceutical Products -- Pharmaceutical Product Development: Formulation Additives -- Advances in Pharmaceutical Oral Solid Dosage Forms -- Advances in Tablet Production and Tablet Coating -- Formulation Evaluation and Development of Specialized Tablets -- Suspensions: Theory, Formulation, Considerations, Flocculated and Deflocculated Suspensions, Evaluation of Suspension Stability -- Liquid and poly-disperse systems: Emulsions -- Sterile Products and Admixtures -- Challenges and Advances in Pharmaceutical Development of Topical and Transdermal Dosage Forms -- Advances in Ophthalmic Formulations Development -- Advances and Developments in Formulation of Drug Nanocrystals -- A Technological Update on Inhalation Drug Delivery Devices -- Herbal Formulations: Development, Challenges, Testing, Stability, and Regulatory Guidelines -- Drug Repurposing and Virtual Screening -- Preclinical and Clinical Studies, Pharmacovigilance, Pharmacogenomics, and Commercialization of Pharmaceutical Products. |
| Record Nr. | UNINA-9910988286303321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Analytical Methods for Tobacco and Nicotine Harm Reduction / / by Serban Moldoveanu, Robert Owen Bussey
| Analytical Methods for Tobacco and Nicotine Harm Reduction / / by Serban Moldoveanu, Robert Owen Bussey |
| Autore | Moldoveanu Serban |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (685 pages) |
| Disciplina | 543 |
| Altri autori (Persone) | BusseyRobert Owen |
| Soggetto topico |
Analytical chemistry
Spectrum analysis Mass spectrometry Chemicals - Safety measures Pharmacovigilance Analytical Chemistry Spectroscopy Mass Spectrometry Chemical Safety Drug Safety and Pharmacovigilance |
| ISBN |
9783031930676
9783031930669 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | General information about tobacco and nicotine products -- Total particulate matter (TPM), “tar”, water, nicotine, and carbon monoxide -- Acetamide and acrylamide -- Aflatoxins -- Ammonia -- Aromatic amines -- Carbonyl compounds -- Chlorinated dioxins/furans -- Heterocyclic aromatic amines -- Hydrogen cyanide. |
| Record Nr. | UNINA-9911018665003321 |
|
Moldoveanu Serban
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / / edited by Mukesh Nandave
| Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers : A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview / / edited by Mukesh Nandave |
| Autore | Nandave Mukesh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (609 pages) |
| Disciplina | 615 |
| Soggetto topico |
Pharmacology
Pharmacovigilance Medicine - Research Biology - Research Clinical biochemistry Therapeutics Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry |
| ISBN | 981-9773-80-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_ Introduction of the renin-angiotensin-aldosterone system (RAAS) -- Chapter 2_ Role of anti-hypertensive agents in cardiovascular disorders -- Chapter 3_ (ACE) Angiotensin-converting enzyme inhibitors: Preferred RAAS inhibitor in high-risk patients as compared to angiotensin receptor blockers (ARBs) -- Chapter 4_ Role of (ACE) angiotensin-converting enzyme inhibitors in transforming renin–angiotensin system -- Chapter 5_ The effect of (ACE) Angiotensin-converting enzyme inhibitors vs angiotensin receptor blockers on insulin resistance in hypertensive patients -- Chapter 6_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure -- Chapter 7_ Immunomodulator activity of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients -- Chapter 8_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peripheral artery disease -- Chapter 9_ Role of (ACE) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in covid-19 patients -- Chapter 10_ Recent trends in the management of hypertension through RAAS inhibition. |
| Record Nr. | UNINA-9910899893503321 |
|
Nandave Mukesh
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antibiotic Resistance in the Environment : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong
| Antibiotic Resistance in the Environment : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XII, 344 p. 1 illus.) |
| Disciplina | 616.9041 |
| Collana | The Handbook of Environmental Chemistry |
| Soggetto topico |
Environmental chemistry
Pharmacology Microbiology Pharmacovigilance Medical microbiology Environmental Chemistry Drug Safety and Pharmacovigilance Medical Microbiology Resistència als medicaments Efecte dels medicaments sobre els microorganismes Química ambiental |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-55065-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Antibiotic resistance in the environment: expert perspectives -- Antibiotic resistant bacteria in wildlife -- Genomic surveillance for One Health antimicrobial resistance: understanding human, animal, and environmental reservoirs and transmission -- Antibiotic resistance in pharmaceutical industry effluents and effluent-impacted environments -- Antibiotic resistance in municipal wastewater: A special focus on hospital effluents -- Control strategies to combat dissemination of antibiotic resistance in urban water systems -- Antibiotic resistance, sanitation and public health -- Antibiotic resistance and sanitation in India: current situation and future perspectives -- Mitigating antimicrobial resistance risks when using reclaimed municipal wastewater for agriculture -- Antibiotic resistance in soil -- Religious Mass Gathering (Hajj) and Antimicrobial Resistance: From Challenges to Opportunities -- Human movement and transmission of anti-microbial resistant bacteria. |
| Record Nr. | UNINA-9910416142403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents / / edited by Michael W. Jann, Scott R. Penzak, Lawrence J. Cohen
| Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents / / edited by Michael W. Jann, Scott R. Penzak, Lawrence J. Cohen |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016 |
| Descrizione fisica | 1 online resource (597 p.) |
| Disciplina | 610 |
| Soggetto topico |
Psychopharmacology
Pharmacy Drug Safety and Pharmacovigilance |
| ISBN | 3-319-27883-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. General Pharmacokinetic and Pharmacodynamic Principles of Psychopharmacological Agents -- 1. Pharmacokinetic Properties -- 2. Pharmacodynamic Properties -- 3. PET Scan and Other Biomarkers -- 4. Population Pharmacokinetics -- 5. Drug Transporters (esp. Blood Brain Barrier) -- 6. Pharmacogenomics -- Section 2. Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Drug Classes -- 7. Antipsychotics – oral typical agents, oral atypical agents, and long-acting injectable (LAI) antipsychotics -- 8. Mood Stabilizers -- 9. Antidepressants – tricyclics, selective serotonergic reuptake inhibitors, serotonergic noradrenergic reuptake inhibitors, monoamine oxidase inhibitors, and other antidepressants -- 10. Benzodiazepines and Other Sedative Hypnotics/Anxiolytics -- 11. Opioid Analgesics -- 12. Stimulants and Other Non-Stimulants for ADHD -- 13. Cholinesterase Inhibitors and Other Antidementa Agents -- 14. Anti-Addiction Agents -- 15. Anesthetics -- Section 3. Clinically Significant Drug Interactions With Psychopharmacological Agents -- 16. Antipsychotics -- 17. Mood Stabilizers -- 18. Antidepressants -- 19. Benzodiazepines and Other Sedative Hypnotics/Anxiolytics -- 20. Opioid Analgesics -- 21. Stimulants and Other Non-Stimulants for ADHD -- 22. Cholinesterase Inhibitors and Other Antidementa Agents -- 23. Anti-Addiction Agents -- 24. Anesthetics. |
| Record Nr. | UNINA-9910254508503321 |
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of Osteoarthritis / / by Nigel Arden, Francisco Blanco, C. Cooper, Ali Guermazi, Daichi Hayashi, David Hunter, M. Kassim Javaid, Francois Rannou, Frank Roemer, Jean-Yves Reginster
| Atlas of Osteoarthritis / / by Nigel Arden, Francisco Blanco, C. Cooper, Ali Guermazi, Daichi Hayashi, David Hunter, M. Kassim Javaid, Francois Rannou, Frank Roemer, Jean-Yves Reginster |
| Autore | Arden Nigel |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014 |
| Descrizione fisica | 1 online resource (99 p.) |
| Disciplina |
353998
610 616723 |
| Soggetto topico |
Rheumatology
Pharmacy Family medicine Drug Safety and Pharmacovigilance General Practice / Family Medicine |
| ISBN | 1-910315-16-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction: historical and current perspectives on osteoarthritis -- Epidemiology of osteoarthritis -- Pathophysiology of osteoarthritis -- Clinical features and diagnosis of osteoarthritis -- Assessing joint damage in osteoarthritis -- Treatment of osteoarthritis. |
| Record Nr. | UNINA-9910300061003321 |
|
Arden Nigel
|
||
| Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Benefit-Risk Assessment of Medicines : The Development and Application of a Universal Framework for Decision-Making and Effective Communication / / by James Leong, Sam Salek, Stuart Walker
| Benefit-Risk Assessment of Medicines : The Development and Application of a Universal Framework for Decision-Making and Effective Communication / / by James Leong, Sam Salek, Stuart Walker |
| Autore | Leong James |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 |
| Descrizione fisica | 1 online resource (326 p.) |
| Disciplina |
306
353998 610 |
| Soggetto topico |
Pharmacy
Medicine - Research Drug Safety and Pharmacovigilance Quality of Life Research |
| ISBN | 3-319-15805-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Prologue -- Preface -- Overview -- Approaches to utilising decision-making framework -- Benefit-risk assessment of medicines by pharmaceutical companies and regulatory authorities -- Development of a universal benefit-risk framework and template -- Implementation of the benefit-risk assessment template by mature agencies -- Implementation of the benefit- risk summary template by a maturing agency: A case study -- Communicating benefit-risk decisions by US FDA, EMA, TGA and Health Canada -- Conclusions and future directions -- References. |
| Record Nr. | UNINA-9910300234003321 |
|
Leong James
|
||
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||